Skip to content
Brand AI

Alibaba Health

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile2 entries

  1. 2024

    Alibaba Health Pharmacy Repeatedly Fined for Illegal Advertising, False Promotion

    In 2024, Alibaba Health Pharmacy was fined RMB 450,000 by the Guangzhou Huangpu District Market Supervision Administration for publishing advertisements for drugs, health foods, and medical devices without review and for falsely promoting therapeutic functions; in 2025, it was fined another RMB 280,000 for advertisements that were not reviewed and contained false and pornographic content. Compliance of the platform's self-operated advertising is being questioned.

    Source

  2. 2021

    China fines Alibaba Health for unreported acquisition

    Fine or penalty

    China's State Administration for Market Regulation fined Alibaba Health RMB 500,000 for implementing a concentration by acquiring a 25% stake in Guizhou Yishu without making the required prior filing. The regulator said the transaction had no effect of eliminating or restricting competition.

    Source excerpt

    • 本机关决定给予阿里健康50万元罚款的行政处罚。
    • 本案不具有排除、限制竞争的效果。
    • 其中，阿里健康科技（中国）有限公司收购贵州一树连锁药业有限公司股权案违反反垄断法，被罚50万元。
    Source